Company Comparison
ContralinePioneering male birth control vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | ContralinePioneering male birth control | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Charlottesville, VA | Lagos, Nigeria |
| Founded | 2015 | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series A | Series B |
| Total Funding | $23M | $45M |
| Valuation | — | — |
What They Build
ContralinePioneering male birth control
Biotechnology company developing innovative male contraceptive solutions including non-hormonal birth control methods.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
ContralinePioneering male birth control
Sector Overlap
Both ContralinePioneering male birth control and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.